Suchergebnisse - "Heterocycles"

PubPharm (259.359)

41

A phase 3b study of venetoclax and azacitidine or decitabine in an outpatient setting in patients with acute myeloid leukemia

enthalten in: Hematological oncology | 2024

von Manda, S. | Anz, B. | Benton, C. | +15

42

Evaluation of antimicrobial and non-steroidal anti-inflammatory treatments for BRD on health and welfare in fattening bulls : a cross-sectional study

enthalten in: The veterinary quarterly | 2024

von Masebo, N. | Marliani, G. | Shannon Del Re, F. | +9

43

Unraveling the rationale and conducting a comprehensive assessment of KD025 (Belumosudil) as a candidate drug for inhibiting adipogenic differentiation-a systematic review

enthalten in: Naunyn-Schmiedeberg's archives of pharmacology | 2024

von Barbalho, S. | de Alvares Goulart, R. | Minniti, G. | +4

44

Privileged small molecules against neglected tropical diseases : A perspective from structure activity relationships

enthalten in: European journal of medicinal chemistry | 2024

von Abbasi Shiran, J. | Kaboudin, B. | Panahi, N. | +1

45

Novel Pyrazole-Chalcone Hybrids : Synthesis and Computational Insights Against Breast Cancer

enthalten in: Chemistry & biodiversity | 2024

von Dabhade, P. | Dabhade, M. | Rathod, L. | +4

46

Vericiguat and Total Heart Failure Hospitalizations

enthalten in: JACC. Heart failure | 2024

von Drazner, M.

47

Efficacy and safety of venetoclax-based combination therapy for previously untreated acute myeloid leukemia : a meta-analysis

enthalten in: Hematology (Amsterdam, Netherlands) | 2024

von He, H. | Wen, X. | Zheng, H.

48

Impact of social determinants of health on time to antiretroviral therapy initiation and HIV viral undetectability for migrants enrolled in a multidisciplinary HIV clinic with rapid, free, and onsite B/F/TAF : 'The ASAP study'

enthalten in: HIV medicine | 2024

von Arora, A. | Vicente, S. | Engler, K. | +16

49

Combining enzalutamide and [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer

enthalten in: The Lancet. Oncology | 2024

von Houédé, N. | Hebert, K.

50

177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p) : an open-label, multicentre, randomised, phase 2 trial

enthalten in: The Lancet. Oncology | 2024

von Emmett, L. | Subramaniam, S. | Crumbaker, M. | +37